Properties of antiviral agents. 2.
D000547:Amantadine / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004267:DNA Viruses / Q000187:drug effects; D005260:Female; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D012328:RNA Viruses / Q000187:drug effects; D012254:Ribavirin / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D012299:Rimantadine / Q000494:pharmacology; D014777:Virus Diseases / Q000188:drug therapy
D000998:Antiviral Agents; D012299:Rimantadine; D012254:Ribavirin; D007372:Interferons; D000547:Amantadine